Toback Seth L - MedImmune | 人才画像

基本信息

浏览量：20

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 81 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Local and Systemic Reactogenicity after Mrna and Protein-Based COVID-19 Vaccines Compared to Meningococcal Vaccine (menacwy) in a UK Blinded, Randomized Phase 2 Trial (COV-BOOST)

Anthony M. Marchese,Hadi Beyhaghi,Matthew D. Rousculp, Vivian Huang,Xinxue Liu,Seth Toback,Saul N. Faust

VACCINE (2025)

引用0浏览0WOS引用

Safety and Immunogenicity of the NVX-CoV2373 Vaccine As a Booster in Adults Previously Vaccinated with the BBIBP-CorV Vaccine

Seth Toback,Anthony M. Marchese, Brandy Warren, Sondos Ayman, Senka Zarkovic,Islam Eltantawy,Raburn M. Mallory,Matthew Rousculp, Fahed Almarzooqi,Bartlomiej Piechowski-Jozwiak,Maria-Fernanda Bonilla,Agyad Ebrahim Bakkour,Salah Eldin Hussein,Nawal Al Kaabi

Vaccineno. 7 (2024): 1777-1784

引用2浏览0WOS引用

Reactogenicity Differences Between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (Mrna)-Based COVID-19 Vaccines

Matthew D. Rousculp,Kelly Hollis,Ryan Ziemiecki,Dawn Odom,Anthony M. Marchese, Mitra Montazeri,Shardul Odak,Laurin Jackson,Hadi Beyhaghi,Seth Toback

Vaccinesno. 7 (2024): 802-802

引用1浏览0WOS引用

Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study

Matthew D. Rousculp,Kelly Hollis,Ryan Ziemiecki,Dawn Odom,Anthony M. Marchese, Mitra Montazeri,Shardul Odak,Laurin Jackson, Angela Miller,Seth Toback

VACCINESno. 1 (2024)

引用2浏览0WOS引用

Reactogenicity Differences Between COVID-19 Vaccines: A Prospective Observational Study in the United States and Canada

Matthew D Rousculp,Kelly Hollis,Ryan Ziemiecki,Dawn Odom,Anthony M Marchese, Mitra Montazeri,Shardul Odak,Laurin Jackson,Hadi Beyhaghi,Seth Toback

medrxiv（2024）

引用0浏览0引用

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

CLINICAL INFECTIOUS DISEASES（2023）

引用30浏览0WOS引用

NVX-CoV2373 Vaccine Efficacy Against Hospitalization: Apost Hocanalysis of the PREVENT-19 Phase 3, Randomized, Placebo-Controlled Trial

Anthony M. Marchese,Xiang Zhou,John Kinol,Eddie Underwood,Wayne Woo,Alice McGarry,Hadi Beyhaghi,German Anez,Seth Toback,Lisa M. Dunkle

Vaccine（2023）

引用3浏览0WOS引用

Safety, Efficacy, and Immunogenicity of the NVX-CoV2373 Vaccine

EXPERT REVIEW OF VACCINESno. 1 (2023): 501-517

引用12浏览0WOS引用

Pivoting to Protein: the Immunogenicity and Safety of Protein-Based NVX-CoV2373 As a Heterologous Booster for Inactivated and Viral Vector COVID-19 Vaccines

Anthony M. Marchese,Raj Kalkeri, Muruga Vadivale,Nungruthai Suntronwong,Seth Toback,Yong Poovorawan

EXPERT REVIEW OF VACCINES（2023）

引用3浏览0WOS引用

The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review

Anthony M. Marchese,Matthew Rousculp,John Macbeth,Bruce T. Seet,Hadi Beyhaghi,Seth Toback

JOURNAL OF INFECTIOUS DISEASESno. 2 (2023): e496-e502

引用6浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn